Premium
Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease – authors’ reply
Author(s) -
Zhulina Y.,
Cao Y.,
Amcoff K.,
Carlson M.,
Tysk C.,
Halfvarson J.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13767
Subject(s) - calprotectin , faecal calprotectin , medicine , gastroenterology , inflammatory bowel disease , confidence interval , disease , crohn's disease , clinical endpoint , clinical trial , immunology